203 related articles for article (PubMed ID: 16205109)
1. Intensive inhibition of hTERT expression by a ribozyme induces rapid apoptosis of cancer cells through a telomere length-independent pathway.
Hao ZM; Luo JY; Cheng J; Li L; He D; Wang QY; Yang GX
Cancer Biol Ther; 2005 Oct; 4(10):1098-103. PubMed ID: 16205109
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of telomerase activity by ribozyme targeted to human telomerase transcriptase].
Qu Y; Liu SQ; Peng WZ; Liu BL
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 May; 34(3):323-8. PubMed ID: 12019445
[TBL] [Abstract][Full Text] [Related]
3. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
6. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
Goldkorn A; Blackburn EH
Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
[TBL] [Abstract][Full Text] [Related]
7. [Hammerhead ribozyme against human telomerase catalytic subunit (hTERT) induced apoptosis of liver cancer cells].
Song DP; Lin JS; Fu GL; Sun XM; Kong XJ; Li PY; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):616-9. PubMed ID: 15504295
[TBL] [Abstract][Full Text] [Related]
8. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
9. Silencing of the hTERT gene by shRNA inhibits colon cancer SW480 cell growth in vitro and in vivo.
Liu AQ; Ge LY; Lu XL; Luo XL; Cai YL; Ye XQ; Geng FF
PLoS One; 2014; 9(9):e107019. PubMed ID: 25207650
[TBL] [Abstract][Full Text] [Related]
10. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
[TBL] [Abstract][Full Text] [Related]
11. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
12. [Attenuation of telomerase activity by hammerhead ribozyme targeting the 5'-end of hTERT mRNA].
Qu Y; Liu S; Liu B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):389-92. PubMed ID: 12362313
[TBL] [Abstract][Full Text] [Related]
13. Design of a ribozyme targeting human telomerase reverse transcriptase and cloning of it's gene.
Hao ZM; Luo JY; Cheng J; Wang QY; Yang GX
World J Gastroenterol; 2003 Jan; 9(1):104-7. PubMed ID: 12508361
[TBL] [Abstract][Full Text] [Related]
14. p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells.
Jones KR; Elmore LW; Jackson-Cook C; Demasters G; Povirk LF; Holt SE; Gewirtz DA
Int J Radiat Biol; 2005 Jun; 81(6):445-58. PubMed ID: 16308915
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
He H; Xia HH; Wang JD; Gu Q; Lin MC; Zou B; Lam SK; Chan AO; Yuen MF; Kung HF; Wong BC
Cancer; 2006 Mar; 106(6):1243-9. PubMed ID: 16444744
[TBL] [Abstract][Full Text] [Related]
16. Gene expression responses in vivo by human telomerase reverse transcriptase (hTERT)-targeting trans-splicing ribozyme.
Song MS; Jeong JS; Cho KS; Lee SW
Exp Mol Med; 2007 Dec; 39(6):722-32. PubMed ID: 18160843
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human telomerase reverse transcriptase in hep-2 cells using short hairpin RNA expression vectors.
Chen SM; Tao ZZ; Hua QQ; Liu D; Chi HM; Cai Q
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):200-5. PubMed ID: 16490880
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of telomerase activity by HDV ribozyme in cancers.
Lu Y; Gu J; Jin D; Gao Y; Yuan M
J Exp Clin Cancer Res; 2011 Jan; 30(1):1. PubMed ID: 21208462
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells.
Yeo M; Rha SY; Jeung HC; Hu SX; Yang SH; Kim YS; An SW; Chung HC
Int J Cancer; 2005 Apr; 114(3):484-9. PubMed ID: 15551309
[TBL] [Abstract][Full Text] [Related]
20. The role of telomerase and viruses interaction in cancer development, and telomerase-dependent therapeutic approaches.
Salimi-Jeda A; Badrzadeh F; Esghaei M; Abdoli A
Cancer Treat Res Commun; 2021; 27():100323. PubMed ID: 33530025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]